IP Library Granted Patent US 10,226,415
Granted Patent B2
US 10,226,415 · App. 14/001,901 · Granted Mar 12, 2019

Antiperspirant/deodorant compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,226,415
App. No.
14/001,901
Granted
Mar 12, 2019
Kind
B2
Abstract

Disclosed are new and improved antiperspirant/deodorant compositions and methods of reducing perspiration, where the new and improved antiperspirant/deodorant compositions contain a water dispersible organic polymer and can reduce the concentration of active antiperspirant ingredients while maintaining antiperspirant efficacy.

Claims (14)

1. An antiperspirant/deodorant composition comprising:

(i) 0.1 wt. % to 20 wt. % of at least one active antiperspirant ingredient; and

(ii) 7 wt. % to 20 wt. % of a water dispersible organic polymer comprising free carboxylic acid group(s),

wherein the water dispersible organic polymer

a) is a 2,5-Furandione polymer with 1,9-decadiene and methoxy ether;

b) has an acid value greater than 200; and

c) is separated from the active antiperspirant ingredient.

2. The antiperspirant/deodorant composition of claim 1 , wherein said water dispersible organic polymer has an acid value greater than about 350.

3. The antiperspirant/deodorant composition of claim 1 , further comprising a second water dispersible organic polymer, wherein said second water dispersible organic polymer comprises a product of a polymerization reaction of acrylic acid, citraconic acid, crotonic acid, maleic acid, methacrylic acid, methylenesuccinic acid, or combinations thereof.

4. The antiperspirant/deodorant composition of claim 1 , wherein said second water dispersible organic polymer comprises latent acid groups.

5. The antiperspirant/deodorant composition of claim 1 , wherein said second water dispersible organic polymer comprises a product of a polymerization reaction of an alkyl vinyl ether, ethylene, isobutylene, propylene, vinyl acetate, or combinations thereof.

6. The antiperspirant/deodorant composition of claim 5 , wherein said alkyl vinyl ether is methyl vinyl ether or ethyl vinyl ether.

7. The antiperspirant/deodorant composition claim 1 , wherein said antiperspirant/deodorant composition is in the form of a stick, gel, lotion, aerosol, fluid, cream, or powder.

8. A method of controlling perspiration and/or malodor of a human, the method comprising applying the antiperspirant/deodorant composition of claim 1 to the skin of a human.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CHANGE OF NAME Recorded May 24, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 042560/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2013
From: FARES, HANI M.; PRETTYPAUL, DONALD I.
To: ISP INVESTMENTS INC.
Reel/Frame 031097/0662 →